Joshua Logan, MD
Urology · Anchorage, AKNPI 1902067390
Payments from drug & device makers
What this record shows
This record is dominated by education: $12,021 of the $15,575 with a category attached, or 77.2%. Intuitive Surgical accounts for 80.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $12,863 and has fallen 96.2% since, to $494 in 2025. Among urology clinicians in AK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $113.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$13K
- C. R. Bard, Inc. & Subsidiaries$621
- Boston Scientific$517
- Johnson & Johnson$398
- Sumitomo Pharma America, Inc.$226
- AbbVie$195
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,55423%
- Education$12,02177%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $12,580 |
| C. R. Bard, Inc. & Subsidiaries | 27 | $621 |
| Boston Scientific | 17 | $517 |
| Johnson & Johnson | 19 | $398 |
| Sumitomo Pharma America, Inc. | 4 | $226 |
| AbbVie(2 entities) | 8 | $195 |
| Rochester Medical Corporation | 13 | $137 |
| 180 Medical, Inc. | 3 | $135 |
| Pfizer | 5 | $95 |
| Astellas Pharma US Inc | 4 | $87 |
| Tersera Therapeutics LLC | 2 | $55 |
| Laborie Medical Technologies Corp. | 2 | $54 |
| Myovant Sciences Inc. | 2 | $51 |
| AstraZeneca | 2 | $49 |
| Bayer | 3 | $49 |
| Olympus America Inc. | 3 | $47 |
| EDAP Technomed Inc | 3 | $42 |
| Novartis | 2 | $39 |
| Insmed, Inc. | 1 | $35 |
| Urogen Pharma, Inc. | 2 | $33 |
| Amgen | 1 | $32 |
| Seagen Inc. | 1 | $22 |
| Angiodynamics, Inc. | 1 | $19 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Photocure Inc | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$12,576
- GEMTESA$153
How this compares
$15,575 in reported general payments places this provider in the 95th percentile of 28 urology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 19 | $25,412 |
| GemtesaVibegron | 14 | $18,182 |
| Silodosin | 24 | $4,446 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 12 | $2,662 |
| Tamsulosin Hcl | 107 | $2,541 |
| Tadalafil | 19 | $1,889 |
| Dutasteride | 31 | $1,219 |
| Desmopressin Acetate | 13 | $740 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 18 | $533 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $497 |
| Finasteride | 16 | $243 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $86 |
| Ciprofloxacin Hcl | 26 | $67 |
| Oxycodone Hcl | 31 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $87 | $25,41219 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $226 | $18,18214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 urology providers in Alaska.
Other urology in Anchorage
- William ClarkAnchorage$9K
- Elysia SpencerAnchorage$8K
- Andre GodetAnchorage$5K
- Bryan WilsonAnchorage$4K
- Mariam MillerAnchorage$4K
- Sarah BeebeAnchorage$3K
- Zachary PoseyAnchorage$2K
- Nancy GillcristAnchorage$2K
- Paul FerucciAnchorage$1K
- Owen AftrethAnchorage$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.